July 19, 2017 | Baltimore (USA)
The Mérieux Foundation has been inducted as a Global Virus Network (GVN) Center for Excellence. Dr. Robert Gallo, Co-Founder and Scientific Director of the GVN, and Dr. Benoît Miribel, Director General of the Mérieux Foundation announced the Mérieux Foundation as the newest GVN Center of Excellence. Dr. Miribel will serve as Director of the Mérieux Foundation’s GVN Center of Excellence.
With thirty-nine Centers of Excellence and six affiliates spanning twenty-four countries around the world, the GVN represents the foremost experts in every class of virus causing disease in humans. The GVN is a global authority and resource for the identification, investigation, and control of viral diseases that threaten mankind. Its work is two-fold, enhancing the international capacity for prevention and response to these viruses, and providing coordinated medical virology recruitment and training through scholarly exchange programs.
“Adding the Fondation Mérieux to the GVN will boost GVN’s already impressive mission to combat deadly diseases,” said Guy Vernet, PhD, senior staff scientist Advanced Bioscience Laboratories Inc. (ABL), Board of Advisors member, Mérieux Foundation USA and Board of Directors member, GVN. “The Foundation’s impressive laboratories and diagnostics programs are key components of the public health response to epidemic infectious diseases, especially in resource-limited, tropical countries, and they will boost GVN’s resources, expertise and capabilities tremendously.”
“The Foundation’s mission synergizes so closely with that of the GVN’s mission”
“We were unanimous in our decision to induct the Mérieux Foundation into the GVN,” said Robert Gallo, who, in addition to his role at GVN, was co-discoverer of HIV, and works as the Homer and Martha Gudelsky Distinguished Professor in Medicine and as the Director of the Institute of Human Virology at the University of Maryland School of Medicine, a GVN Center of Excellence. “We are so pleased that the Foundation’s mission synergizes so closely with that of the GVN’s mission. The GVN looks forward to building its international capacity with the help of the Foundation’s world renowned clinical biological laboratories, collaborative research and training programs, and local initiatives.”
The Mérieux Foundation’s mission is to contribute to global health by strengthening local capacities of developing countries to reduce the impact of infectious diseases, such as pneumonia, HIV or Zika fever, on vulnerable populations. The Foundation offers a specific model based on a long history of expertise in clinical biology and a comprehensive approach to public health issues. Its international scientific network, GABRIEL, brings together researchers in sixteen countries to work on collaborative applied research programs.
“Better structure international cooperation in the field of research on infectious diseases”
The Mérieux Foundation’s research network includes three laboratories in Africa, four in the Americas, eight in Asia, and four in Europe and the Middle East. “We look forward to joining forces with the Global Virus Network and contributing our expertise to strengthen an already impressive organization,” says Benoît Miribel, Director General of the Mérieux Foundation. “We have an existing strong presence in Africa, the Americas, Asia and Europe. In partnership with the GVN we will better structure international cooperation in the field of research on infectious diseases, a pillar of our work, and help train the next generation of medical virologists.”
About the Global Virus Network (GVN)
The Global Virus Network (GVN) is a non-profit, US 501(c)(3) organization, comprised of leading medical virologists from twenty-four countries. The GVN’s mission is to combat current and emerging pandemic viral threats through international collaborative research, training the next generation of medical virologists, and advocacy.